ProQR Therapeutics N.V.

NASDAQ:PRQR

3.98 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 6.3374.4763.21.371.2050.6550.8220.9561.0251.2340.2390.8720.243000001.9330004.941000-1.5290002.2820009.4070000.30900000
Cost of Revenue 0.7150.69500000.7130000000.6470000116.8230000000000000000000000000
Gross Profit 5.6223.7813.21.371.2050.6550.1090.9561.0251.2340.2390.8720.243-0.6470000-114.890004.941000-1.5290002.2820009.4070000.30900000
Gross Profit Ratio 0.8870.84511110.13311111100000-59.4360001000100010001000100000
Reseach & Development Expenses 7.0849.3387.5355.4465.9096.0610.69915.35211.44913.36712.45611.1249.7358.9058.4198.3048.58712.82513.93111.0749.52311.9639.5426.2975.997.6858.3457.2267.5528.038.18.3198.6066.8986.49465.4275.483.2732.4573.2721.2651.2690.686
General & Administrative Expenses 3.0133.4524.753.3154.1454.0262.9725.3595.4124.9085.3164.5914.1223.3393.5122.8093.4463.9183.9172.9032.8763.1914.642.5792.6492.6722.8912.7532.8922.3042.262.0012.6152.6021.9991.4581.7771.6031.9972.381.5350.5950.3460.196
Selling & Marketing Expenses -0.699-0.675-0.83100000000000000000000000000000000000000000
SG&A 2.3142.7773.9193.3154.1454.0262.9725.3595.4124.9085.3164.5914.1223.3393.5122.8093.4463.9183.9172.9032.8763.1914.642.5792.6492.6722.8912.7532.8922.3042.262.0012.6152.6021.9991.4581.7771.6031.9972.381.5350.5950.3460.196
Other Expenses 0.351-0.068-0.0560.1180.259-0.042-0.7650.0790.161-0.101-0.302-0.3250.378-0.7290.485-0.3050.0340.0340.4240.0120.5630.4161.3332.9580.110.4990.5110.3260.1110.120.1030.4470.0450.6890.9581.19100.3380.309000.00400
Operating Expenses 9.39712.11511.4538.76110.05410.04412.90620.71116.86118.17417.77215.71513.85712.10311.93110.8623.35916.4817.84813.44712.39915.15414.1828.8767.77810.35711.2369.97910.2910.06110.3610.3210.6779.58.4937.4586.4567.0835.274.8374.8071.861.4990.882
Operating Income -3.775-8.334-8.963-7.391-8.811-9.389-12.358-19.681-15.737-16.94-17.328-14.557-13.203-12.103-11.667-10.862-3.359-16.48-17.424-13.447-11.836-14.738-12.849-5.918-7.668-9.858-10.725-9.653-10.179-9.941-10.257-9.873-10.632-8.811-7.535-6.267-6.456-6.745-4.961-4.837-4.807-1.856-1.615-0.882
Operating Income Ratio -0.596-1.862-2.801-5.395-7.312-14.334-15.034-20.587-15.353-13.728-72.502-16.694-54.33300000-9.014000-2.60007.014000-4.495000-0.801000-16.05500000
Total Other Income Expenses Net 0.8680.6343.6261.5670.360.5340.968-4.6311.0872.497-0.387-0.4570.378-0.2150.433-0.389-0.052-0.1340.274-0.1191.2610.4161.3332.9580.110.4990.5110.3260.1110.120.1030.4470.0450.6890.9581.1910.7480.3380.3091.4620.0110.004-0.1350.006
Income Before Tax -2.907-7.7-5.337-5.461-8.019-8.855-11.39-24.312-14.65-14.443-18.218-15.034-15.7-12.611-13.19-13.114-4.108-16.078-18.511-12.191-11.669-14.244-12.977-5.992-7.399-10.717-11.311-10.521-11.363-10.478-8.819-10.127-9.959-10.198-6.126-6.317-8.6240.235-2.037-3.375-4.796-1.919-1.634-0.876
Income Before Tax Ratio -0.459-1.72-1.668-3.986-6.655-13.519-13.856-25.431-14.293-11.704-76.226-17.241-64.60900000-9.576000-2.6260007.398000-3.865000-0.651000-6.59200000
Income Tax Expense -0.2010.0030.005-0.041-0.042-0.864-0.7580.0690.020.0070.0220.0350.0530.0070.0380.0750.011-0.0230.068-0.0520.064-0.087-0.057-0.0330.001-0.058-0.028-0.011.1840.002-1.4380.254-0.6731.387-1.4090.052.916-6.98-2.924000.0630.0240
Net Income -2.706-7.703-5.342-5.71-7.993-7.991-10.632-24.381-14.67-14.45-18.221-15.047-15.746-12.607-13.217-13.181-4.112-16.055-18.534-12.139-11.651-14.157-12.944-5.959-7.342-10.659-11.283-10.511-11.363-10.48-8.819-10.127-9.959-10.198-6.126-6.317-8.6240.235-2.037-3.375-4.796-1.919-1.634-0.876
Net Income Ratio -0.427-1.721-1.67-4.168-6.633-12.2-12.934-25.503-14.312-11.71-76.238-17.256-64.79800000-9.588000-2.620007.379000-3.865000-0.651000-6.59200000
EPS -0.033-0.094-0.068-0.071-0.099-0.099-0.14-0.34-0.21-0.2-0.26-0.22-0.24-0.25-0.26-0.26-0.082-0.32-0.39-0.31-0.3-0.36-0.33-0.18-0.23-0.33-0.39-0.42-0.47-0.45-0.38-0.43-0.43-0.44-0.26-0.27-0.370.01-0.087-0.43-0.23-0.086-0.074-0.039
EPS Diluted -0.033-0.094-0.068-0.071-0.099-0.099-0.14-0.34-0.21-0.2-0.26-0.22-0.24-0.25-0.26-0.26-0.082-0.32-0.39-0.31-0.3-0.36-0.33-0.18-0.23-0.33-0.39-0.42-0.47-0.45-0.38-0.43-0.43-0.44-0.26-0.27-0.370.01-0.087-0.43-0.23-0.086-0.074-0.039
EBITDA -3.06-7.639-8.254-8.198-8.356-9.248-11.397-15.127-16.389-16.37-16.981-14.299-13.012-12.093-11.279-10.6-2.829-15.958-17.339-12.941-11.883-14.633-13.915-8.634-7.535-10.117-10.978-9.712-10.018-9.793-10.093-10.036-10.317-9.166-8.351-7.332-6.339-6.988-5.209-4.811-4.785-1.843-1.462-0.874
EBITDA Ratio -0.483-1.707-2.579-5.984-6.934-14.119-13.865-15.823-15.989-13.266-71.05-16.398-53.54700000-8.97000-2.8160007.18000-4.423000-0.888000-16.85800000